erlotinib hydrochloride has been researched along with Leukokeratosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, DO; Garrett, CG; McWhorter, A; Misono, S; Somerville, J | 1 |
1 other study(ies) available for erlotinib hydrochloride and Leukokeratosis
| Article | Year |
|---|---|
Resolution of vocal fold leukoplakia during erlotinib treatment for lung cancer.
Topics: Aged; Antineoplastic Agents; ErbB Receptors; Erlotinib Hydrochloride; Humans; Incidental Findings; Laryngeal Neoplasms; Leukoplakia; Lung Neoplasms; Male; Vocal Cords | 2016 |